BAGSVAERD, DENMARK--(Marketwire - March 18, 2013) -
Company announcement No 19 / 2013:
http://hugin.info/2013/R/1685937/552525.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE
[HUG#1685937]
Further information
Media:
Katrine Sperling
+45 3079 6718
Email Contact
Ken Inchausti
+1 609 786 8316
Email Contact
Ambre Morley
+1 609 987 5898
Email Contact
Investors:
Kasper Roseeuw Poulsen
+45 4442 4303
Email Contact
Frank Daniel Mersebach
+45 4442 0604
Email Contact
Lars Borup Jacobsen
+45 3075 3479
Email Contact
Jannick Lindegaard (US)
+1 609 786 4575
Email Contact